Skip to content

A Bilateral Dispensing Clinical Trial of Sapphire Lens Against Senofilcon A Lens Over 2 Weeks

A Bilateral Dispensing Clinical Trial of Sapphire Lens Against Senofilcon A Lens Over 2 Weeks

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02345811
Enrollment
34
Registered
2015-01-26
Start date
2015-01-31
Completion date
2015-03-31
Last updated
2020-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperopia, Myopia

Brief summary

To evaluate the clinical performance of an investigational silicone-hydrogel lens when worn on a daily wear modality over two weeks of lens wear.

Detailed description

This was a randomized, bilateral, 2 week cross over, double-masked, dispensing study comparing Sapphire test lens against the senofilcon A control lens. This study results were not used to support design validation of the test lens.

Interventions

DEVICESapphire

silicone-hydrogel contact lens

DEVICEsenofilcon A

contact lens

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
17 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Is at least 17 years of age for Canada and 18 years of age for the USA and has full legal capacity to volunteer * Has read and signed an information consent letter * Is willing and able to follow instructions and maintain the appointment schedule; * Is an adapted soft contact lens wearer * Requires spectacle lens powers between -0.50 to -6.00 diopters sphere (0.25D steps) or +1.00 to +8.00 diopters sphere (1.00D steps) * Has no more than 0.75 diopters of refractive astigmatism * Willing to wear contact lens in both eyes * Has manifest refraction visual acuities (VA) equal to or better than logMAR equivalent of 20/25 in each eye * To be eligible for lens dispensing, the subject must have VA of logMAR equivalent of 20/30 or better in each eye with the study lenses and the investigator must judge the fit as acceptable

Exclusion criteria

* Is participating in any concurrent clinical or research study * Has any known active\* ocular disease and/or infection * Has a systemic condition that in the opinion of the investigator may affect a study outcome variable * Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable * Has known sensitivity to the diagnostic pharmaceuticals to be used in the study * Is pregnant, lactating or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit) * Is aphakic * Has undergone refractive error surgery

Design outcomes

Primary

MeasureTime frameDescription
Subjective Preference for Comfort.Baseline - 10 minutes post lens settlingSubjective rating for comfort. Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever
Vision QualityBaseline (10 minutes post lens settling at dispense)Subjective rating for vision quality. Collected at dispense after settling of each study pair. (0-100 scale; 0=extremely poor vision, 100=excellent vision)
Subjective Rating for Comfort.Baseline - 10 minutes post lens settlingSubjective rating for comfort. Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever
Lens Surface WettabilityBaseline (10 minutes post lens settling)Lens surface wettability assessed. Scale 0-4, 0.25 steps, 0=nonwetting, 4=excellent)
Surface DepositsBaseline (10 minutes post lens settling)Surface deposits is assessed. (Scale 0-4,0.25 steps) (0=no deposits; 1 = \<5 deposits; 2 = \>5 deposits or film 25-50% of surface; 3 = deposits 0.1 - 0.5mm or film 50-75% of surface; 4 = deposits \>0.5mm or film \> 75% of surface)
Lens Handling (Ease of Insertion)2 weeksLens handling - ease of insertion of the lenses. Scale 0-100, 0=could not place lens on eye, 100=always easy to place lens on eye.
Lens Handling (Ease of Removal)2 weeksLens handling - ease of removal of the lenses. Scale 0-100, 0=could not remove lens from eye, 100=always easy to remove lens from eye.

Countries

Canada, United States

Participant flow

Participants by arm

ArmCount
Overall Study
Subjects were randomized to wear either the test lens or the control lens for 2 weeks and then cross-over to the other lens. Test Lens: Sapphire (contact lens) Control Lens : Senofilcon A (contact lens)
32
Total32

Withdrawals & dropouts

PeriodReasonFG000FG001
First InterventionWithdrawal by Subject11

Baseline characteristics

CharacteristicOverall Study
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
32 Participants
Age, Continuous24 years
STANDARD_DEVIATION 9
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Canada
15 participants
Region of Enrollment
United States
17 participants
Sex: Female, Male
Female
25 Participants
Sex: Female, Male
Male
7 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 320 / 32
other
Total, other adverse events
2 / 322 / 32
serious
Total, serious adverse events
0 / 320 / 32

Outcome results

Primary

Lens Handling (Ease of Insertion)

Lens handling - ease of insertion of the lenses. Scale 0-100, 0=could not place lens on eye, 100=always easy to place lens on eye.

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
SapphireLens Handling (Ease of Insertion)93 units on a scaleStandard Deviation 10
Senofilcon ALens Handling (Ease of Insertion)95 units on a scaleStandard Deviation 8
Primary

Lens Handling (Ease of Removal)

Lens handling - ease of removal of the lenses. Scale 0-100, 0=could not remove lens from eye, 100=always easy to remove lens from eye.

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
SapphireLens Handling (Ease of Removal)90 units on a scaleStandard Deviation 14
Senofilcon ALens Handling (Ease of Removal)95 units on a scaleStandard Deviation 7
Primary

Lens Surface Wettability

Lens surface wettability assessed. Scale 0-4, 0.25 steps, 0=nonwetting, 4=excellent)

Time frame: Baseline (10 minutes post lens settling)

ArmMeasureValue (MEAN)Dispersion
SapphireLens Surface Wettability3.2 units on a scaleStandard Deviation 0.6
Senofilcon ALens Surface Wettability3.2 units on a scaleStandard Deviation 0.7
Primary

Lens Surface Wettability

Lens surface wettability assessed. Scale 0-4, 0.25 steps, 0=nonwetting, 4=excellent)

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
SapphireLens Surface Wettability3.0 units on a scaleStandard Deviation 0.8
Senofilcon ALens Surface Wettability3.2 units on a scaleStandard Deviation 0.6
Primary

Subjective Preference for Comfort.

Subjective rating for comfort. Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever

Time frame: 2 weeks

ArmMeasureGroupValue (NUMBER)
SapphireSubjective Preference for Comfort.Sapphire23 percentage of participants
SapphireSubjective Preference for Comfort.senofilcon A68 percentage of participants
SapphireSubjective Preference for Comfort.No preference9 percentage of participants
Primary

Subjective Preference for Comfort.

Subjective rating for comfort. Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever

Time frame: Baseline - 10 minutes post lens settling

ArmMeasureGroupValue (NUMBER)
SapphireSubjective Preference for Comfort.Sapphire22 percentage of participants
SapphireSubjective Preference for Comfort.senofilcon A53 percentage of participants
SapphireSubjective Preference for Comfort.No preference25 percentage of participants
Primary

Subjective Rating for Comfort.

Subjective rating for comfort. Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever

Time frame: 2-weeks - During the Day

ArmMeasureValue (MEAN)Dispersion
SapphireSubjective Rating for Comfort.76 units on a scaleStandard Deviation 20
Senofilcon ASubjective Rating for Comfort.87 units on a scaleStandard Deviation 13
Primary

Subjective Rating for Comfort.

Subjective rating for comfort. Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever

Time frame: Baseline - 10 minutes post lens settling

ArmMeasureValue (MEAN)Dispersion
SapphireSubjective Rating for Comfort.91 units on a scaleStandard Deviation 12
Senofilcon ASubjective Rating for Comfort.92 units on a scaleStandard Deviation 11
Primary

Subjective Rating for Comfort.

Subjective rating for comfort. Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever

Time frame: 2-weeks - End of Day

ArmMeasureValue (MEAN)Dispersion
SapphireSubjective Rating for Comfort.66 units on a scaleStandard Deviation 26
Senofilcon ASubjective Rating for Comfort.81 units on a scaleStandard Deviation 17
Primary

Surface Deposits

Surface deposits is assessed. (Scale 0-4,0.25 steps) (0=no deposits; 1 = \<5 deposits; 2 = \>5 deposits or film 25-50% of surface; 3 = deposits 0.1 - 0.5mm or film 50-75% of surface; 4 = deposits \>0.5mm or film \> 75% of surface)

Time frame: 2-weeks

ArmMeasureValue (MEAN)Dispersion
SapphireSurface Deposits0.45 units on a scaleStandard Deviation 0.51
Senofilcon ASurface Deposits0.40 units on a scaleStandard Deviation 0.51
Primary

Surface Deposits

Surface deposits is assessed. (Scale 0-4,0.25 steps) (0=no deposits; 1 = \<5 deposits; 2 = \>5 deposits or film 25-50% of surface; 3 = deposits 0.1 - 0.5mm or film 50-75% of surface; 4 = deposits \>0.5mm or film \> 75% of surface)

Time frame: Baseline (10 minutes post lens settling)

ArmMeasureValue (MEAN)Dispersion
SapphireSurface Deposits0.05 units on a scaleStandard Deviation 0.18
Senofilcon ASurface Deposits0.16 units on a scaleStandard Deviation 0.4
Primary

Vision Quality

Subjective rating for vision quality. Collected at dispense after settling of each study pair. (0-100 scale; 0=extremely poor vision, 100=excellent vision)

Time frame: Baseline (10 minutes post lens settling at dispense)

ArmMeasureValue (MEAN)Dispersion
SapphireVision Quality93 units on a scaleStandard Deviation 9
Senofilcon AVision Quality94 units on a scaleStandard Deviation 7
Primary

Vision Quality

Subjective rating for vision quality. Collected at dispense after settling of each study pair. (0-100 scale; 0=extremely poor vision, 100=excellent vision)

Time frame: 2 weeks - End of Day

ArmMeasureValue (MEAN)Dispersion
SapphireVision Quality86 units on a scaleStandard Deviation 14
Senofilcon AVision Quality87 units on a scaleStandard Deviation 14
Primary

Vision Quality

Subjective rating for vision quality. Collected at dispense after settling of each study pair. (0-100 scale; 0=extremely poor vision, 100=excellent vision)

Time frame: 2 weeks - During the Day

ArmMeasureValue (MEAN)Dispersion
SapphireVision Quality88 units on a scaleStandard Deviation 12
Senofilcon AVision Quality91 units on a scaleStandard Deviation 11

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026